P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINASE DEFICIENCY PATIENTS RECEIVING LONG-TERM TREATMENT WITH MITAPIVAT

Podobne knjige/članki

• P1473: CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB-ANALYSIS OF THE ACTIVATE TRIAL
  od: Hanny Al-Samkari, et al.
  Izdano: (2023-08-01)
• P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL
  od: Rachael F. Grace, et al.
  Izdano: (2023-08-01)
• P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINASE DEFICIENCY PATIENTS RECEIVING LONG-TERM TREATMENT WITH MITAPIVAT
  od: H. Al-Samkari, et al.
  Izdano: (2022-06-01)
• Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
  od: Hanny Al-Samkari, et al.
  Izdano: (2021-12-01)
• P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
  od: Eduard van Beers, et al.
  Izdano: (2023-08-01)